
GL
Globe Life Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
143.000
Open
142.600
VWAP
--
Vol
53.84K
Mkt Cap
11.83B
Low
142.120
Amount
--
EV/EBITDA(TTM)
9.72
Total Shares
92.27M
EV
14.40B
EV/OCF(TTM)
--
P/S(TTM)
2.07
Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
1.56B
+5.18%
3.515
+14.5%
1.53B
+4.5%
3.540
+12.74%
1.52B
+4.22%
4.172
+19.54%
Estimates Revision
The market is revising Upward the revenue expectations for Globe Life Inc. (GL) for FY2025, with the revenue forecasts being adjusted by 0.09% over the past three months. During the same period, the stock price has changed by 15.80%.
Revenue Estimates for FY2025
Revise Upward

+0.09%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Up

+15.80%
In Past 3 Month
10 Analyst Rating

-0.30% Downside
Wall Street analysts forecast GL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GL is 142.40 USD with a low forecast of 118.00 USD and a high forecast of 168.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
3 Hold
0 Sell
Moderate Buy

-0.30% Downside
Current: 142.830

Low
118.00
Averages
142.40
High
168.00

-0.30% Downside
Current: 142.830

Low
118.00
Averages
142.40
High
168.00
Keefe Bruyette
Keefe Bruyette
Outperform
maintain
$155 -> $165
2025-07-29
New
Reason
Keefe Bruyette
Keefe Bruyette
Price Target
$155 -> $165
2025-07-29
New
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Globe Life to $165 from $155 and keeps an Outperform rating on the shares after the company announced the Department of Justice closed its investigation into its sales practices with no enforcement action. The firm says the news ends the risk that began for Globe Life in April 2024. Keefe cites the company's history of growing premiums and earnings for the target bump.
Keefe Bruyette
Keefe Bruyette
Outperform
maintain
$155 -> $160
2025-07-29
New
Reason
Keefe Bruyette
Keefe Bruyette
Price Target
$155 -> $160
2025-07-29
New
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Globe Life to $160 from $155 and keeps an Outperform rating on the shares after the company announced the Department of Justice closed its investigation into its sales practices with no enforcement action. The firm says the news ends the risk that began for Globe Life in April 2024. Keefe cites the company's history of growing premiums and earnings for the target bump.
Keefe Bruyette
Outperform
maintain
$145 -> $155
2025-07-28
New
Reason
Keefe Bruyette
Price Target
$145 -> $155
2025-07-28
New
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Globe Life to $155 from $145 and keeps an Outperform rating on the shares.
Morgan Stanley
Bob Huang
Equal Weight
maintain
$127 -> $135
2025-07-25
New
Reason
Morgan Stanley
Bob Huang
Price Target
$127 -> $135
2025-07-25
New
maintain
Equal Weight
Reason
Morgan Stanley analyst Bob Huang raised the firm's price target on Globe Life to $135 from $127 and keeps an Equal Weight rating on the shares. With "marginally better than expected" earnings and a large share price move, some investors asked how durable is the post results share price appreciation, notes the analyst, who views the share price rebound as "justified." However, the firm believes the company needs further clarity from the DOJ probe for the stock to see additional upside, the analyst added.
Truist
Buy
initiated
$150
2025-07-15
Reason
Truist
Price Target
$150
2025-07-15
initiated
Buy
Reason
Truist initiated coverage of Globe Life with a Buy rating and $150 price target. The firm says the company's diversified model that supports steady returns while the shares trade at a discount to peers. The stock can now be bought at a discount valuation because of a "misguided" short report and short-term volatility in medical utilization, the analyst tells investors in a research note.
Morgan Stanley
Bob Huang
Equal Weight
maintain
$125 -> $127
2025-07-14
Reason
Morgan Stanley
Bob Huang
Price Target
$125 -> $127
2025-07-14
maintain
Equal Weight
Reason
Morgan Stanley analyst Bob Huang raised the firm's price target on Globe Life to $127 from $125 and keeps an Equal Weight rating on the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Globe Life Inc (GL.N) is 9.17, compared to its 5-year average forward P/E of 10.72. For a more detailed relative valuation and DCF analysis to assess Globe Life Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
10.72
Current PE
9.17
Overvalued PE
12.63
Undervalued PE
8.80
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
9.63
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.20
Undervalued EV/EBITDA
8.05
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
1.82
Current PS
0.00
Overvalued PS
2.05
Undervalued PS
1.59
Financials
Annual
Quarterly
FY2025Q2
YoY :
+2.85%
1.48B
Total Revenue
FY2025Q2
YoY :
-2.24%
348.18M
Operating Profit
FY2025Q2
YoY :
-2.17%
252.75M
Net Income after Tax
FY2025Q2
YoY :
+7.77%
3.05
EPS - Diluted
FY2025Q1
YoY :
+22.96%
420.14M
Free Cash Flow
FY2025Q2
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q2
YoY :
-4.91%
17.06
Net Margin - %
FY2025Q2
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 792.12% over the last month.
Sold
0-3
Months
9.2M
USD
5
3-6
Months
548.6K
USD
2
6-9
Months
16.6M
USD
11
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1440.51% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
736.5K
Volume
2
6-9
Months
47.8K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
70.0K
Volume
Months
6-9
5
165.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.0K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
32.5K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 792.12% over the last month.
Sold
0-3
Months
9.2M
USD
5
3-6
Months
548.6K
USD
2
6-9
Months
16.6M
USD
11
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
GL News & Events
Events Timeline
2025-07-29 (ET)
2025-07-29
09:55:01
Early notable gainers among liquid option names on July 29th

2025-07-28 (ET)
2025-07-28
17:49:56
Globe Life announces closing of Department of Justice investigation

2025-07-24 (ET)
2025-07-24
18:20:08
Globe Life announces conclusion of SEC investigation

Sign Up For More Events
Sign Up For More Events
News
4.0
07-29BenzingaKeefe, Bruyette & Woods Maintains Outperform on Globe Life, Raises Price Target to $160
7.0
07-28NewsfilterGlobe Life Announces Closing of Department of Justice Investigation
4.0
07-28BenzingaKeefe, Bruyette & Woods Maintains Outperform on Globe Life, Raises Price Target to $155
Sign Up For More News
People Also Watch

PNW
Pinnacle West Capital Corp
90.580
USD
+0.79%

AIT
Applied Industrial Technologies Inc
272.720
USD
+0.12%

BBDO
Banco Bradesco SA
2.460
USD
+0.41%

UWMC
UWM Holdings Corp
4.116
USD
-1.77%

MGM
MGM Resorts International
37.680
USD
+0.72%

RBC
RBC Bearings Inc
384.810
USD
-0.07%

RRC
Range Resources Corp
36.575
USD
+0.23%

WPP
WPP PLC
27.420
USD
-0.65%

PRI
Primerica Inc
262.750
USD
-1.59%

WAL
Western Alliance Bancorp
80.370
USD
+0.04%
FAQ

What is Globe Life Inc (GL) stock price today?
The current price of GL is 142.83 USD — it has decreased -0.31 % in the last trading day.

What is Globe Life Inc (GL)'s business?

What is the price predicton of GL Stock?

What is Globe Life Inc (GL)'s revenue for the last quarter?

What is Globe Life Inc (GL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Globe Life Inc (GL)'s fundamentals?

How many employees does Globe Life Inc (GL). have?
